Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
Biomerica, Inc. (BMRA)
NASDAQ:AMEX Investor Relations:
biomerica.com/company/investor.asp
Company Research
Source: GlobeNewswire
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors- Relationship Marks a Key Milestone in Biomerica’s Commercialization Strategy IRVINE, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, to market Biomerica’s inFoods® Irritable Bowel Syndrome (IBS) test in the United States, excluding New York State. Henry Schein’s powerful nationwide distribution network, comprised of more than 400 medical field sales and telesales representatives, will provide marketing support for the inFoods® IBS test to primary care and gastroenterology specialty practices. With more than 93 years in health care innovation and over $12 billion in annual sales in 2024, Henry Schein is well-p
Show less
Read more
Impact Snapshot
Event Time:
BMRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRA alerts
High impacting Biomerica, Inc. news events
Weekly update
A roundup of the hottest topics
BMRA
News
- Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS [Yahoo! Finance]Yahoo! Finance
- Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBSGlobeNewswire
- Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market DemandGlobeNewswire
- Biomerica Reports First Quarter Fiscal 2026 Financial ResultsGlobeNewswire
- Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors [Yahoo! Finance]Yahoo! Finance
BMRA
Sec Filings
- 10/23/25 - Form DEFA14A
- 10/20/25 - Form DEF
- 10/14/25 - Form 10-Q
- BMRA's page on the SEC website